Publications of Tiago F. Outeiro
All genres
Journal Article (129)
41.
Journal Article
147 (1), 40 (2024)
Regional AT-8 reactive tau species correlate with intracellular Aβ levels in cases of low AD neuropathologic change. Acta Neuropathologica 42.
Journal Article
18, pp. 68 - 71 (2024)
Prion meeting 2023: implications of a growing field. Prion 43.
Journal Article
1869 (8), 166835 (2023)
Glycation modulates superoxide dismutase 1 aggregation and toxicity in models of sporadic amyotrophic lateral sclerosis. Biochimica et Biophysica Acta-Molecular Basis of Disease 44.
Journal Article
146, pp. 369 - 385 (2023)
More than meets the eye in Parkinson’s disease and other synucleinopathies: from proteinopathy to lipidopathy. Acta Neuropathologica 45.
Journal Article
166 (5), pp. 862 - 874 (2023)
Proteomic analysis of the human hippocampus identifies neuronal pentraxin 1 (NPTX1) as synapto-axonal target in late-stage Parkinson's disease. Journal of Neurochemistry 46.
Journal Article
38 (9), pp. 1585 - 1597 (2023)
Extracellular Vesicles for the Diagnosis of Parkinson's Disease: Systematic Review and Meta-Analysis. Movement Disorders 47.
Journal Article
24 (17), 13435 (2023)
Changes in α-Synuclein Posttranslational Modifications in an AAV-Based Mouse Model of Parkinson’s Disease. International Journal of Molecular Sciences 48.
Journal Article
29 (1), 111 (2023)
The alpha-synuclein oligomers activate nuclear factor of activated T-cell (NFAT) modulating synaptic homeostasis and apoptosis. Molecular Medicine 49.
Journal Article
39 (4-6), pp. 321 - 335 (2023)
Uncovering the Molecular Link Between Lead Toxicity and Parkinson's Disease. Antioxidants & redox signaling 50.
Journal Article
19 (8), pp. 453 - 454 (2023)
AI and protein structure and function in neurological disease: relevance to disease management. Nature Reviews Neurology 51.
Journal Article
38 (7), pp. 1127 - 1142 (2023)
Defining the riddle in order to solve it: There is more than one "Parkinson's Disease". Movement Disorders 52.
Journal Article
123 (14), pp. 9094 - 9138 (2023)
Targeting Biomolecular Condensation and Protein Aggregation against Cancer. Chemical Reviews 53.
Journal Article
13 (4), pp. 633 - 636 (2023)
People with early onset Parkinson’s disease: empowered to improve care. Journal of Parkinson's Disease: JPD 54.
Journal Article
29 (33), e202300649 (2023)
Chemical Synthesis of Alpha-Synuclein Proteins via Solid-Phase Peptide Synthesis and Native Chemical Ligation. Chemistry – A European Journal 55.
Journal Article
14, 1918 (2023)
Genipin prevents alpha-synuclein aggregation and toxicity by affecting endocytosis, metabolism and lipid storage. Nature Communications 56.
Journal Article
13 (2), pp. 179 - 196 (2023)
miR-101a-3p Impairs Synaptic Plasticity and Contributes to Synucleinopathy. Journal of Parkinson's Disease: JPD 57.
Journal Article
23, 174 (2023)
Glycosylation spectral signatures for glioma grade discrimination using Raman spectroscopy. BMC Cancer 58.
Journal Article
177, 105995 (2023)
The immune system in Parkinson's disease: From biology to diagnosis and therapeutic targets. Neurobiology of Disease 59.
Journal Article
11 (8), 2209 (2023)
Genome-Wide Expression Profile in People with Optic Neuritis Associated with Multiple Sclerosis. Biomedicines 60.
Journal Article
11 (2), 505 (2023)
Stem Cell Therapies in Movement Disorders: Lessons from Clinical Trials. Biomedicines